David Funt, MD
Cardiovascular Disease · Boca Raton, FLNPI 1780671248
Payments from drug & device makers
Across 524 payments — averaging $5342.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1M
- Novartis$498K
- Boehringer Ingelheim International GmbH$291K
- Cleerly, Inc.$288K
- Modernatx, Inc.$200K
- Amgen$152K
- plus $323K from 19 others
Across 5 payments — averaging $29,471 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$147K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 28 | $1,047,958 |
| Novartis | 18 | $497,669 |
| Boehringer Ingelheim International GmbH | 383 | $291,289 |
| Cleerly, Inc. | 23 | $287,638 |
| Modernatx, Inc. | 15 | $199,613 |
| Amgen | 9 | $152,326 |
| Merck | 7 | $118,567 |
| Astrazeneca UK Limited | 1 | $85,160 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 5 | $62,534 |
| Alnylam Pharmaceuticals Inc. | 9 | $32,933 |
| Regeneron | 1 | $17,500 |
| Bayer | 1 | $3,915 |
| Ionis Pharmaceuticals, Inc. | 1 | $1,000 |
| Astellas Pharma US Inc | 3 | $297 |
| Organon | 1 | $220 |
| AbbVie(2 entities) | 3 | $184 |
| Abbott | 1 | $144 |
| Novo Nordisk | 1 | $107 |
| Philips North America LLC | 3 | $97 |
| Merz North America, Inc. | 2 | $74 |
| Pfizer | 3 | $51 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $27 |
| Boston Scientific | 1 | $26 |
| AstraZeneca | 1 | $15 |
| Preventice Services, LLC | 1 | $12 |
How this compares
$2,799,357 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Boca Raton
- Seth BaumBoca Raton$11.1M
- Michael KorenGainesville$31M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.